MetaADEDB 2.0 @ LMMD
alvimopan
(UPNUIXSCZBYVBB-JVFUWBCBSA-N)
Structure
SMILES
OC(=O)CNC(=O)[C@@H](Cc1ccccc1)CN1CC[C@@]([C@H](C1)C)(C)c1cccc(c1)O
Type(s)
Approved; Investigational
ATC code(s)
A06AH02
Molecular Formula:
C25H32N2O4
Molecular Weight:
424.533
Log P:
3.3802
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
3
TPSA:
89.87
CAS Number(s):
145590-44-9; 156053-89-3
Synonym(s)
1.
alvimopan
2.
ADL 8-2698
3.
ADL8-2698
4.
Entereg
5.
LY 246736
6.
LY-246736
7.
LY246736
8.
alvimopan anhydrous
9.
anhydrous alvimopan
10.
trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine
External Link(s)
MeSHC419502
PubChem Compound51397022
5488548
BindingDB50088381
ChEBI135686
CHEMBLCHEMBL270190
DrugBankDB06274
DrugCentral143
IUPHAR/BPS Guide to PHARMACOLOGY7471
KEGGdr:D02878
Therapeutic Target DatabaseD0D7KC
ZINC3802417
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute myocardial infarctionFAERS: 5OFFSIDES
US FAERS
2Atrial FibrillationFAERS: 1US FAERS
3Cerebrovascular accidentFAERS: 1US FAERS
4Drug dose omissionFAERS: 1US FAERS
5Intestinal infarctionFAERS: 1US FAERS
6Unevaluable eventFAERS: 1US FAERS
7Ventricular FibrillationFAERS: 1OFFSIDES
US FAERS
8Abdominal Pain18164818CTD
OFFSIDES
9Abdominal discomfortOFFSIDES
10Acute Coronary SyndromeOFFSIDES
11Anastomotic LeakOFFSIDES
12Anastomotic complicationOFFSIDES
13Aortic valve calcificationOFFSIDES
14Aortic valve sclerosisOFFSIDES
15Back PainSIDER
16Blood and lymphatic system disordersSIDER
17Blood glucose decreasedOFFSIDES
18Blood pressure inadequately controlledOFFSIDES
19Carotid pulse increasedOFFSIDES
20Choking sensationOFFSIDES
21Clostridium difficile colitisOFFSIDES
22ColectomyOFFSIDES
23Congenital tricuspid valve incompetenceOFFSIDES
24Constipation18164818
21292168
21292169
CTD
SIDER
25Diarrhea18164818CTD
OFFSIDES
26DyspepsiaSIDER
27FlatulenceSIDER
28Gastrointestinal Diseases11180040CTD
29Gastrointestinal disorder postoperativeOFFSIDES
30Gastrointestinal perforationOFFSIDES
31Gastrointestinal stoma complicationOFFSIDES
32HypercapniaOFFSIDES
33Ileus

View details

CTD
34InfectionOFFSIDES
35Intentional drug misuseOFFSIDES
36Intestinal ObstructionOFFSIDES
37Leukopenia neonatalOFFSIDES
38MalnutritionSIDER
39Mental status changesOFFSIDES
40Nausea18164818CTD
OFFSIDES
41Portal Vein ThrombosisOFFSIDES
42Post procedural complicationOFFSIDES
43Post procedural myocardial infarctionOFFSIDES
44Post procedural pulmonary embolismOFFSIDES
45Postoperative Complications

View details

CTD
46Postoperative renal failureOFFSIDES
47Procedural complicationOFFSIDES
48Procedural hypotensionOFFSIDES
49Respiratory FailureOFFSIDES
50Septic ShockOFFSIDES
51Silent myocardial infarctionOFFSIDES
52Supraventricular tachycardiaOFFSIDES
53Troponin increasedOFFSIDES
54Urinary RetentionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.